JY
BDSX icon

Jeff Yass’s Biodesix BDSX Stock Holding History

Jeff Yass’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,090
Closed -$335K – 13382
2026
Q1 		$335K Buy
+23,090
New +$286K ﹤0.01% 10630
2025
Q2 		– Sell
-29,971
Closed -$375K – 12654
2025
Q1 		$375K Sell
29,971
-25,816
-46% -$495K ﹤0.01% 9566
2024
Q4 		$1.71M Buy
55,787
+49,373
+770% +$1.45M ﹤0.01% 5670
2024
Q3 		$228K Buy
+6,414
New +$221K ﹤0.01% 10186
2024
Q2 		– Sell
-9,519
Closed -$272K – 12044
2024
Q1 		$272K Buy
9,519
+8,732
+1,110% +$299K ﹤0.01% 9919
2023
Q4 		$29K Buy
+787
New +$24.7K ﹤0.01% 11890
2023
Q2 		– Sell
-1,841
Closed -$68.5K – 12061
2023
Q1 		$68.5K Buy
+1,841
New +$75.6K ﹤0.01% 11537

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Jeff Yass's BDSX Position: Q2 2026 in Review

Jeff Yass sold out of Biodesix (BDSX) in Q2 2026, closing a stake of 23,090 shares — an estimated $335K sold.

Jeff Yass first reported a position in BDSX in Q1 2023 and held it in 7 quarters. The position peaked at $1.71M in Q4 2024. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Jeff Yass reported no remaining Biodesix position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 23,090 Biodesix shares in Q2 2026, an estimated $335K.
  • Jeff Yass first reported a position in Biodesix in Q1 2023 and held it in 7 quarters.
  • Jeff Yass's Biodesix position peaked at $1.71M in Q4 2024.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.